MedTrace Logo

CMR in T2DM: The NSR Cohort

NCT05915260 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2023-06-22

No results posted yet for this study

Summary

This study aims to investigate the myocardial phenotype of patients with type 2 diabetes. From 2016-2019 the investigators recruited a cohort of 296 subjects with type 2 diabetes. All subjects underwent clinical examinations including a gadolinium contrast cardiac MRI.

The current study is a clinical follow-up study of the subjects, thus, the investigators will invite all participants to a reevaluation with cardiac MRI.

Additionally, the investigators will aim at recruiting additionally 400 patients with type 2 diabetes.

The aim it to characterize the phenotype of diabetic cardiomyopathy. Uniquely using cardiac MRI we can measure myocardial microvascular function, myocardial localised and diffuse fibrosis in addition to the quantification of myocardial structure and systolic and diastolic function.

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetic Cardiomyopathies
  • Cardiovascular Magnetic Resonance Imaging
  • Coronary Microvascular Dysfunction
  • Myocardium; Fibrosis

Interventions

DIAGNOSTIC_TEST

All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion

This is a observational follow up study accordingly all subjects will undergo the same examinations

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER

  • Slagelse Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-12-31
Completion
2030-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05915260 on ClinicalTrials.gov